Former Chairman and CEO 2 · Perspective Therapeutics, Inc. (CATX)

Thomas LaVoy

A named executive officer of Perspective Therapeutics in every fiscal year CompBrief holds from FY2017 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$677,733

Salary $291,739Stock awards $0

FY2017: $642,507

1st of 4 named executive officers at Perspective Therapeutics by FY2018 total.

4 named officers on file for Perspective Therapeutics, FY2018

Thomas LaVoy’s pay file — $29

  • 2 fiscal years of pay, line by line
  • CATX’s disclosed peer group of 25 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Perspective Therapeutics’s whole pay program stands against its peers

  • Perspective Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CATX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed November 9, 2018 (DEF 14A).

Free

Get Thomas LaVoy’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Thomas LaVoy compensation by year

Perspective Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Perspective Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018
Salary$300,583$291,739
Bonus$0$0
Stock awards$0$0
Option awards$329,901$0
Non-equity incentive$12,023$25,250
Pension and deferred compensation$0$0
All other$0$360,745
Total$642,507$677,733

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Perspective Therapeutics, Inc. DEF 14A filed November 9, 2018, accession 0001437749-18-020263, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Perspective Therapeutics, Inc. filed document, accession 0001437749-18-020263. Every figure is read from that document and cited to the page and table it appears in. Filed November 9, 2018.

$643K
$678K
FY17
FY18
SalaryNon-equity incentiveOption awardsAll other

Perspective Therapeutics’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Thomas LaVoy · this pageFormer Chairman and CEO 2$677,733
Michael KrachonVP - S&M$314,925
William CavanaghCRDO$287,524
Lori WoodsCEO and Director$107,911

The full Perspective Therapeutics compensation record

free company brief

This page is one person within Perspective Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Perspective Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Perspective Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Thomas LaVoy's compensation dossier · One-time report. No refunds.